Do coxibs reduce prescription of gastroprotective agents? Results of a record linkage study
<p>Abstract</p> <p>Background</p> <p>Coxibs are claimed to be cost-effective drugs and reduced prescription of gastroprotective agents is assumed to be one of their major benefits. Real life prescription of these drugs may be substantially different than that considered...
Main Authors: | Violante Andrea, Voci Claudio, Menna Angelo, Formoso Giulio, Magrini Nicola |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-03-01
|
Series: | Cost Effectiveness and Resource Allocation |
Online Access: | http://www.resource-allocation.com/content/4/1/4 |
Similar Items
-
Recommendations for the Appropriate Use of Anti-Inflammatory Drugs in the Era of the Coxibs: Defining the Role of Gastroprotective Agents
by: Richard H Hunt, et al.
Published: (2002-01-01) -
Pharmacoutilization of anti-inflammatory and gastroprotective drugs in patients with osteoarthritis: comparison between COXIBs and conventional NSAIDs by using administrative records
by: Luca Degli Esposti, et al.
Published: (2006-01-01) -
Colorectal cancer and Coxibs Cáncer colorrectal y Coxibs
by: C. Taxonera, et al.
Published: (2004-10-01) -
Analysis of the Health and Budgetary Impact of Chondroitin Sulfate Prescription in the Treatment of Knee Osteoarthritis Compared to NSAIDs and COXIBs
by: Rubio-Terrés C, et al.
Published: (2020-09-01) -
Evaluation model of the effect of Rofecoxib on the co-prescription of gastroprotective agents observed during the treatment of ostheoarthritis
by: P. Russo, et al.
Published: (2002-12-01)